{"schema_version":"secwatch.filing_event.v1","accession":"0001757073-23-000078","form_type":"8-K","ticker":"NVST","cik":"0001757073","company_name":"Envista Holdings Corp","filed_at":"2023-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.328697+00:00","generated_at":"2026-06-07T12:55:47.943871+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Envista names three new executives; Nobel Biocare president exits Dec 31","bullets":["Patrik Eriksson, SVP and President of Nobel Biocare, departs effective Dec 31, 2023.","Robert Befidi appointed President, Diagnostics; previously led division at 3M.","Suraj Satpathy appointed Chief Human Resources Officer; formerly SVP HR at Cepheid.","Andrew Chen appointed Chief Information Officer; previously CIO at Kite Pharma.","External search for permanent CFO is underway; CEO Aghdaei directly overseeing Nobel Biocare."],"urls":{"canonical":"https://secwatch.observer/filing/0001757073-23-000078","json":"https://secwatch.observer/filing/0001757073-23-000078.json","markdown":"https://secwatch.observer/filing/0001757073-23-000078.md","text":"https://secwatch.observer/filing/0001757073-23-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757073/000175707323000078/0001757073-23-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757073/000175707323000078/nvst-20231211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T12:55:47.943871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"afb7124cb7","claim":"Patrik Eriksson resigned as SVP and President, Nobel Biocare at Envista Holdings Corp.","evidence_excerpt":"On December 11, 2023, Envista Holdings Corporation (the “Company”) and Patrik Eriksson, the Company’s SVP and President, Nobel Biocare, mutually agreed that Mr. Eriksson’s employment will terminate effective December 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1757073/000175707323000078/0001757073-23-000078-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"SVP and President, Nobel Biocare"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}